Skip to content

Effect of different Omega-3 supplementations

A randomized open label pilot clinical study to evaluate the effect of omega-3 supplementation in healthy subjects

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023143
Enrollment
80
Registered
2020-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Omega-3 enriched egg: One Omega-3 enriched egg daily for 30 days Intervention2: Omega-3 enriched eggs: One Omega-3 enriched egg twice daily for 30 days Intervention3: Fish oil capsule:

Sponsors

Arjuna Natural Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy male and female subjects aged 18-65 years Willing to participate in the study and sign the informed consent form

Exclusion criteria

Exclusion criteria: Subject allergic to egg, fish oil or omega-3 supplements. Subject consuming omega-3 supplements or having used Omega 3 supplements in 6 months preceding the intervention period. Subjects with uncontrolled hypertension (SBP >=160 mm Hg or DBP >=100 mmHg), coronary artery disease, uncontrolled diabetes, renal impairment, cerebrovascular and peripheral artery disease which under the opinion of the investigator would influence the conduct or outcome of the study. Subjects with history of alcohol abuse, other sedatives or drugs. Subjects participated in another clinical study in the past 3 months

Design outcomes

Primary

MeasureTime frame
Change in Omega -3 fatty acid level in blood plasma at Day 15 and Day 30 compared to baselineTimepoint: Baseline, Day 15, Day 30

Secondary

MeasureTime frame
Change in Lipid profile, Serum calcium, Urine calcium at Day 15 and Day 30 compared to baseline Timepoint: Baseline, Day 15, Day 30

Countries

India

Contacts

Public ContactDr Binu T Kuruvilla

Arjuna Natural Private Limited

drbinu@arjunanatural.com09447818432

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026